logo

Incyte Corporation (INCY)



Trade INCY now with
  Date
  Headline
6/29/2020 7:14:24 AM Incyte Announces Approval Of Tabrecta In Japan For Patients With Advanced NSCLC With METex14
5/14/2020 9:34:56 AM MorphoSys, Incyte Report Updated Results From Ongoing Phase 2 L-MIND Study
5/5/2020 7:23:21 AM Incyte Q1 Loss Per Share $3.33 Vs EPS $0.47 Last Year
3/16/2020 6:46:54 AM Lilly And Incyte: FDA Grants Breakthrough Therapy Designation To Baricitinib
2/13/2020 7:09:06 AM Incyte Q4 GAAP EPS $0.51; Non-GAAP EPS $0.65